{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2026-01-03T12:22:35.358134+00:00",
  "news": [
    {
      "title": "2025 at Amgen: Investing, Expanding, and Serving More Patients - Amgen",
      "link": "https://news.google.com/rss/articles/CBMingFBVV95cUxOcWprWDR1WDBZZHhaOHM3NVBFRXlsd3d2UTRQQjU2cnlmS2hkVEFSb1lJX3A1dUlvbnZrRVZ1N0lXTXJsWGVNeWRXZ0d1T0t0Z0F0d2g3RzlWOXRnM1Ffa3FhVTloLW5yNmMzcGNCWURtN3ZBVU1lT0RING5tc3cxX284Z2JBVk14VlREWDJlRDF4MS1weHBtU2tzYlRvZw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMingFBVV95cUxOcWprWDR1WDBZZHhaOHM3NVBFRXlsd3d2UTRQQjU2cnlmS2hkVEFSb1lJX3A1dUlvbnZrRVZ1N0lXTXJsWGVNeWRXZ0d1T0t0Z0F0d2g3RzlWOXRnM1Ffa3FhVTloLW5yNmMzcGNCWURtN3ZBVU1lT0RING5tc3cxX284Z2JBVk14VlREWDJlRDF4MS1weHBtU2tzYlRvZw?oc=5\" target=\"_blank\">2025 at Amgen: Investing, Expanding, and Serving More Patients</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Amgen</font>",
      "published": "2025-12-17T08:00:00+00:00",
      "source": "Amgen"
    },
    {
      "title": "AMGEN TAKES ACTION WITH THE U.S. GOVERNMENT TO LOWER THE COST OF MEDICINES FOR AMERICAN PATIENTS - PR Newswire",
      "link": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxQcWpiRG9leU85RUVNSFpKeE5kQ1FrTlRCcnc1V3lqM05nbGdtLTREUUNPUlRmZVZQQVFlXzI1b2VPN2Z1bTlCdlN6UUxhN3YwanhaZTdHQ2lXNEtfdVJXdTVJM1ZPUXVDeENVV1NjbnhlbHVDMnpjQzMweFVsNmk5U2diRV8zbGpBdGZQRzk0eHp3SmFHOXhhZTZkQXlnMDdkd1FPa1JwN1ZFVlZrb1Y1UGdLOURHZy1wVmFmQWZ5clFRUnJIT0F2MGlFb2NNdDZKYlBfdmM3ZVBubGdmOGwyYUNxV3o?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi5AFBVV95cUxQcWpiRG9leU85RUVNSFpKeE5kQ1FrTlRCcnc1V3lqM05nbGdtLTREUUNPUlRmZVZQQVFlXzI1b2VPN2Z1bTlCdlN6UUxhN3YwanhaZTdHQ2lXNEtfdVJXdTVJM1ZPUXVDeENVV1NjbnhlbHVDMnpjQzMweFVsNmk5U2diRV8zbGpBdGZQRzk0eHp3SmFHOXhhZTZkQXlnMDdkd1FPa1JwN1ZFVlZrb1Y1UGdLOURHZy1wVmFmQWZ5clFRUnJIT0F2MGlFb2NNdDZKYlBfdmM3ZVBubGdmOGwyYUNxV3o?oc=5\" target=\"_blank\">AMGEN TAKES ACTION WITH THE U.S. GOVERNMENT TO LOWER THE COST OF MEDICINES FOR AMERICAN PATIENTS</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
      "published": "2025-12-19T08:00:00+00:00",
      "source": "PR Newswire"
    },
    {
      "title": "Amgen stock dips as Lumakras combo trial ends; MariTide data now the next watch - ts2.tech",
      "link": "https://news.google.com/rss/articles/CBMioAFBVV95cUxONU9YZ2xmNkN5clRqWGhjN0U0T1U2cFBlRi1vQ2U0T1B1OGhYUzdkdS1meFFmOU9MTTc5eVU3STdaVnhGekljdU41cE9oZkNPZERTYVdMTkwyNFNNU0J0M1RuWUg3b2hIMDVIamxMMHJ5NmJKUDgwTHVfRi1VUmwweGVLR2hKYXMzTWU3YVh2V0E5enBkZXcwV0NjVEtlTUQ1?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMioAFBVV95cUxONU9YZ2xmNkN5clRqWGhjN0U0T1U2cFBlRi1vQ2U0T1B1OGhYUzdkdS1meFFmOU9MTTc5eVU3STdaVnhGekljdU41cE9oZkNPZERTYVdMTkwyNFNNU0J0M1RuWUg3b2hIMDVIamxMMHJ5NmJKUDgwTHVfRi1VUmwweGVLR2hKYXMzTWU3YVh2V0E5enBkZXcwV0NjVEtlTUQ1?oc=5\" target=\"_blank\">Amgen stock dips as Lumakras combo trial ends; MariTide data now the next watch</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">ts2.tech</font>",
      "published": "2025-12-30T20:09:44+00:00",
      "source": "ts2.tech"
    },
    {
      "title": "SteelPeak Wealth LLC Sells 52,953 Shares of Amgen Inc. $AMGN - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPZjdLRnliUWszVDdiaUNPNjRjcXU1OUlWajNwTVpibjB5VTBEN2R3SzlESmJ4OGhKNU1qQmVLLWdGRTRsWU5vR3lyWjdEWERNLVBnaTNJUDdXYnBtTC1kaFBPUml0ODc0ZGdUUG54bTY0MWRIVWpKTW43enl1dVhWOUNZV1ZBVDNaNnZKVjBDV0tPYXdUTDIxcEF3NkNoTWVuTzZsOWNkLXctVDZmYnJjWmxUZFB1SkNHbVE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiugFBVV95cUxPZjdLRnliUWszVDdiaUNPNjRjcXU1OUlWajNwTVpibjB5VTBEN2R3SzlESmJ4OGhKNU1qQmVLLWdGRTRsWU5vR3lyWjdEWERNLVBnaTNJUDdXYnBtTC1kaFBPUml0ODc0ZGdUUG54bTY0MWRIVWpKTW43enl1dVhWOUNZV1ZBVDNaNnZKVjBDV0tPYXdUTDIxcEF3NkNoTWVuTzZsOWNkLXctVDZmYnJjWmxUZFB1SkNHbVE?oc=5\" target=\"_blank\">SteelPeak Wealth LLC Sells 52,953 Shares of Amgen Inc. $AMGN</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2026-01-02T12:41:18+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "Amgen Strikes Drug Pricing Deal With Trump: What Investors Should Know - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMigwFBVV95cUxPVHk5ZjUtSkQ3Y2htRFFIZTJ5SmhVazBpWmpSR1FPRm53UWd1Q3V3SXF6Y0hBSzdlYUtCdFlJSUZaalNXUVZHUjJTelc0YTZLempHZzJVZjE3SFB4RHROWlpMRHhFdGI4U09UR1gxZGY4cExJX0VDdHN0QkYyNXJJSjVjNA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMigwFBVV95cUxPVHk5ZjUtSkQ3Y2htRFFIZTJ5SmhVazBpWmpSR1FPRm53UWd1Q3V3SXF6Y0hBSzdlYUtCdFlJSUZaalNXUVZHUjJTelc0YTZLempHZzJVZjE3SFB4RHROWlpMRHhFdGI4U09UR1gxZGY4cExJX0VDdHN0QkYyNXJJSjVjNA?oc=5\" target=\"_blank\">Amgen Strikes Drug Pricing Deal With Trump: What Investors Should Know</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-12-24T08:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Amgen's Uplizna breaks into crowded myasthenia gravis market with FDA nod - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPdzdabm5oVWZTbklRTE1GUEdQWFNOTnFQOFdUZF9rU2FwZ1ZaRzJoZDdCS1hYdy1ZQUdUNXhSaUNfYmFjV2RjR3MzaTlRNkZSNU1wOHBYcXhkSmw4VUcxRDgzMktpcjk4YktMWmZUNzFCQXRMazJHMThUX2JMUGVOUnAyMWhJQlNQX19OUURxQ3A0dmVZc2dnN201WHJucnFndTdfZ0pB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipgFBVV95cUxPdzdabm5oVWZTbklRTE1GUEdQWFNOTnFQOFdUZF9rU2FwZ1ZaRzJoZDdCS1hYdy1ZQUdUNXhSaUNfYmFjV2RjR3MzaTlRNkZSNU1wOHBYcXhkSmw4VUcxRDgzMktpcjk4YktMWmZUNzFCQXRMazJHMThUX2JMUGVOUnAyMWhJQlNQX19OUURxQ3A0dmVZc2dnN201WHJucnFndTdfZ0pB?oc=5\" target=\"_blank\">Amgen's Uplizna breaks into crowded myasthenia gravis market with FDA nod</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-12-12T08:00:00+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "Amgen (AMGN): Buy, Sell, or Hold Post Q3 Earnings? - TradingView — Track All Markets",
      "link": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNa2xyVWZHT0JxVlRzbFZxX0x6UkdqNzJfSW5TQ2dzQl80S2JfUGRIRmtmUkQtX0I3OENLMXdmci1Ydy1WazE1ODlaRWpKTWI4MWJlSDFxVkg5eFJ2UzdIS1ZESTlKY3hFVEJaZGZGWTU4d21Ic1J5cmxQZFowMVl3T1dWUUlvQWNNTWFTMFBwQmh2elVrY01SUHZmOFFPS0dHdWhXTURMQXY?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNa2xyVWZHT0JxVlRzbFZxX0x6UkdqNzJfSW5TQ2dzQl80S2JfUGRIRmtmUkQtX0I3OENLMXdmci1Ydy1WazE1ODlaRWpKTWI4MWJlSDFxVkg5eFJ2UzdIS1ZESTlKY3hFVEJaZGZGWTU4d21Ic1J5cmxQZFowMVl3T1dWUUlvQWNNTWFTMFBwQmh2elVrY01SUHZmOFFPS0dHdWhXTURMQXY?oc=5\" target=\"_blank\">Amgen (AMGN): Buy, Sell, or Hold Post Q3 Earnings?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TradingView — Track All Markets</font>",
      "published": "2025-12-31T04:01:00+00:00",
      "source": "TradingView — Track All Markets"
    },
    {
      "title": "Amgen Named Official Biotech Partner by Los Angeles Sports & Entertainment Commission (LASEC) Ahead of FIFA World Cup 2026 - Amgen",
      "link": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxPOURKbzJfc1BFUkM4VThkel81UFhMWXVwVVczMEVsX2JoeUZLU0Zxbm5acEZQM2Z1ckEtSldKY3luT3I2em5LX0FDcGpSaW9OSVFSVHRIckl4SHl3LWNDa21VcW1EdVZPX3RJZXhmREJUb0lQaFp4QlNIV2NOcXZQazdVSnZyYTlEM1ZLQmlGaW5OZGo4QlhtSE1DcXk1dWs3blkySUZTZGh5RldlcFlqTW1qM1ItSEE1RHc1ZEotQk10dU1QdTQ0NFBJQnYtcEdHUkFZRnBYMzdwTzJFcmFUZWJKMDhZdGpUUHc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi6gFBVV95cUxPOURKbzJfc1BFUkM4VThkel81UFhMWXVwVVczMEVsX2JoeUZLU0Zxbm5acEZQM2Z1ckEtSldKY3luT3I2em5LX0FDcGpSaW9OSVFSVHRIckl4SHl3LWNDa21VcW1EdVZPX3RJZXhmREJUb0lQaFp4QlNIV2NOcXZQazdVSnZyYTlEM1ZLQmlGaW5OZGo4QlhtSE1DcXk1dWs3blkySUZTZGh5RldlcFlqTW1qM1ItSEE1RHc1ZEotQk10dU1QdTQ0NFBJQnYtcEdHUkFZRnBYMzdwTzJFcmFUZWJKMDhZdGpUUHc?oc=5\" target=\"_blank\">Amgen Named Official Biotech Partner by Los Angeles Sports & Entertainment Commission (LASEC) Ahead of FIFA World Cup 2026</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Amgen</font>",
      "published": "2025-12-05T08:00:00+00:00",
      "source": "Amgen"
    }
  ],
  "product_launches": [
    {
      "title": "Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5\" target=\"_blank\">Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-09-10T07:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-16T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Strong first-quarter product sales for Amgen - The Pharma Letter",
      "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5\" target=\"_blank\">Strong first-quarter product sales for Amgen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Pharma Letter</font>",
      "published": "2025-05-02T07:00:00+00:00",
      "source": "The Pharma Letter"
    },
    {
      "title": "3 major patent losses this year — and a key strategy to fill the gaps - Pharma Voice",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5\" target=\"_blank\">3 major patent losses this year — and a key strategy to fill the gaps</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Pharma Voice</font>",
      "published": "2025-07-21T07:00:00+00:00",
      "source": "Pharma Voice"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2026-01-02",
      "close": 327.6400146484375
    },
    "history": [
      {
        "date": "2025-12-23",
        "close": 331.489990234375
      },
      {
        "date": "2025-12-24",
        "close": 333.9599914550781
      },
      {
        "date": "2025-12-26",
        "close": 332.92999267578125
      },
      {
        "date": "2025-12-29",
        "close": 329.6300048828125
      },
      {
        "date": "2025-12-30",
        "close": 328.69000244140625
      },
      {
        "date": "2025-12-31",
        "close": 327.30999755859375
      },
      {
        "date": "2026-01-02",
        "close": 327.6400146484375
      }
    ],
    "name": "Amgen Inc."
  }
}